[Is haemostasis assessment mandatory in case of pregnancy loss?]

Jean-Christophe Gris1, Eva Cochery-Nouvellon, Eric Mercier

  • 1Laboratoire et Consultations d'Hématologie, Centre Hospitalier Universitaire, Groupe Hospitalo-Universitaire Caremeau, Nîmes, France. jean.christophe.gris@chu-nimes.fr

Revue Medicale Suisse
|March 22, 2011
PubMed

Pregnancy losses must be categorised into biochemical loss, early embryonic loss, late foetal loss and stillbirth cases. No haemostasis-related investigations are necessary for biochemical losses. Antiphospholipid antibodies must be checked for three early losses or one late loss. A complete blood count will reveal the rare essential thrombocytemias, a functional fibrinogen assay the exceptional dysfibrinogenemia cases. Vitamin B12 and intracellular folates levels must be checked in case of clinical or biological suspicion. Constitutive thrombophilias must not be routinely assessed because a therapeutic option is not definitively demonstrated. Screening for constitutive thrombophilias should be only indicated for clinical research purposes, only for late foetal loss and stillbirth cases.